High-Performance Liquid Chromatographic Determination of Fluconazole in Plasma and its Application to a Bioequivalence Study

被引：0

作者：

de Sousa, Carlos E. M. ^{[1
]}

Bedor, Danilo C. G. ^{[1
]}

Sampaio Filho, L. C. A. ^{[1
]}

Silva, T. M. ^{[1
]}

Bonifacio, F. N. ^{[1
]}

Albuquerque, Miracy M. ^{[1
]}

de Santana, Davi P. ^{[1
]}

机构：

[1] Nucleo Desenvolvimento Farmaceut & Cosmet NUDFAC, BR-50740520 Recife, PE, Brazil

来源：

LATIN AMERICAN JOURNAL OF PHARMACY | 2011年 / 30卷 / 07期

关键词：

Bioequivalence; Fluconazole; High performance liquid chromatography (HPLC); Validation; 150; MG; ANTIFUNGAL AGENT; FORMULATIONS; EXTRACTION; DRUG; CAPSULE; SERUM;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A sensitive and accurate HPLC-UV method for the quantification of fluconazole (FNZ) in human plasma has been developed. The sample was prepared by liquid liquid extraction (LLE) of FNZ from plasma using ethyl acetate. Nevirapine (NVP) was used as internal standard. The chromatographic retention times of FNZ and NVP were 3.4 and 5.7 min, respectively. The lower limit of quantitation (LLOQ) was 0.5 mu g/mL, and no interferences were detected in the chromatograms. The HPLC-UV method was validated by evaluating its intra-day and inter-day precisions and accuracies in a linear concentration range between 0.5 and 8.0 mu g/mL. The method was developed, validated and successfully applied to bioequivalence studies involving the oral administration of a single 150 mg FNZ capsules in healthy Brazilian male volunteers.

引用

页码：1432 / 1436

页数：5

共 23 条

[1] Bioequivalence evaluation of two formulations of fluconazole 150 mg capsule in healthy Arab men [J].

Al-Gaai, E ;

Lockyer, M ;

Al-Digither, S ;

Hammami, MM .

BIOPHARMACEUTICS & DRUG DISPOSITION, 2005, 26 (04) :143-146

[2]

Bennett JE., 2006, Goodman Gilman's The Pharmacological Basis of Therapeutics, V11th, P1225

[3] International Interlaboratory Proficiency Testing Program for Measurement of Azole Antifungal Plasma Concentrations [J].

Bruggemann, Roger J. M. ;

Touw, Daan J. ;

Aarnoutse, Rob E. ;

Verweij, Paul E. ;

Burger, David M. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) :303-305

[4] Gender differences in the oral pharmacokinetics of Fluconazole [J].

Carrasco-Portugal, Miriam del C. ;

Flores-Murrieta, Francisco J. .

CLINICAL DRUG INVESTIGATION, 2007, 27 (12) :851-855

[5] Liquid/liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the analysis of fluconazole in human plasma [J].

Eerkes, A ;

Shou, WZ ;

Weng, ND .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (05) :917-928

[6]

Food and Drug Administration, 2001, FDA GUID IND STAT AP

[7] Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection [J].

Gordien, Jean-Baptiste ;

Pigneux, Arnaud ;

Vigouroux, Stephane ;

Tabrizi, Reza ;

Accoceberry, Isabelle ;

Bernadou, Jean-Marc ;

Rouault, Audrey ;

Saux, Marie-Claude ;

Breilh, Dominique .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 50 (05) :932-938

[8] RAPID-DETERMINATION OF SERUM LEVELS OF A NEW ANTIFUNGAL AGENT, FLUCONAZOLE, BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

HOSOTSUBO, KK ;

HOSOTSUBO, H ;

NISHIJIMA, MK ;

OKADA, T ;

TAENAKA, N ;

YOSHIYA, I .

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 529 (01) :223-228

[9] PHARMACOKINETIC EVALUATION OF UK-49,858, A METABOLICALLY STABLE TRIAZOLE ANTIFUNGAL DRUG, IN ANIMALS AND HUMANS [J].

HUMPHREY, MJ ;

JEVONS, S ;

TARBIT, MH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :648-653

[10] DETERMINATION OF FLUCONAZOLE IN HUMAN SERUM BY SOLID-PHASE EXTRACTION AND REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

INAGAKI, K ;

TAKAGI, J ;

LOR, E ;

OKAMOTO, MP ;

GILL, MA .

THERAPEUTIC DRUG MONITORING, 1992, 14 (04) :306-311

← 1 2 3 →